… Principle findings In this review of NICE clinical guidelines, potentially serious drug-drug
interactions were relatively common among recommendations for each of three index con- …

… interactions. Little is known about compliance with pharmacy practice guidelines for the
management of drug–drug interaction alerts. …

… A transparent risk analysis is presented for identification of clinically relevant DDIs with
anticancer drugs. Integration of DDI guidelines into the national electronic prescribing system is …

… regulatory agencies’ guidance documents about drug-drug interactions and contemporary
… methods for the design of clinical pharmacokinetic studies of NPs and NP-drug interactions. …

… the quality of clinical practice guidelines, including checklists … guidelines for the management
of drug–drug interactions (DDIs… guidelines on the practical management of (potential) drug–…

… the “Guideline Category”, “Intended Users”, “Clinical Specialty”… selected clinical practice
guidelines categorized for “Treatment… Medicine” or “Family Practice” clinical specialties. From the …

… Clearly, the risk of clinically important drug-drug interactions … is to focus upon clinically relevant
interactions between AEDs … drug classes, with emphasis on pharmacokinetic interactions. …

… This review discusses drug interaction mechanisms and strategies for … drug interactions.
We also provide future perspectives for reducing the risk of clinically significant drug interactions…

… /harm of drug treatment, including our limited understanding of ADEs and interactions in
people taking large numbers of drugs and the … Clinical guidelines also need to consider making …

… way to deal with the interactions of herbal medicines in this … included the interactions of
herbal medicines for which clinical … amount of clinical data on herbal medicines interactions. Our …